In vitro toxicodynamic models to accelerate drug selection and safety assessment

Birmingham, UK, July 3, 1999

Click here to start

Table of Contents

In vitro toxicodynamic models to accelerate drug selection and safety assessment 

In vivo pharmacokinetics/pharmacodynamics of anti-infectives

PPT Slide

Why may anti-infectives be toxic?

From pharmacokinetics to toxicodynamics ...

Which Pharmacokinetic/Pharmacotoxicologic parameters to take in consideration ? 

PPT Slide

How can models help?

1. Toxicodynamic models for:

Toxicodynamic models for the understanding of aminoglycoside nephrotoxicity

Toxicodynamic models for the understanding of aminoglycoside nephrotoxicity

Toxicodynamic models for the understanding of aminoglycoside nephrotoxicity

Toxicodynamic models for the understanding of aminoglycoside nephrotoxicity

2. Toxicodynamic models for:

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Toxicodynamic models for the discovery of cellular alterations induced by macrolides

Pharmacokinetic parameters revisited in the light of toxicodynamics

Pharmacodynamic parameters revisited in the light of pharmacokinetics

? in vitro models to reduce the working load of in vivo toxicological studies ?

? in vitro models to reduce the working load for in vivo toxicological studies ?

in vitro models to reduce the working load for in vivo toxicological studies

PPT Slide

Publications in toxicology : hit-parade of the models used

Thanks to...

Author: F. Van Bambeke